Eledon Pharmaceuticals (ELDN) Other Non-Current Assets (2013 - 2026)

Eledon Pharmaceuticals (ELDN) has 14 years of Other Non-Current Assets data on file, last reported at $32.4 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 9048.59% year-over-year to $32.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.4 million (up 9048.59% YoY) and the FY2025 annual result came in at $322000.0, down 11.29% from the prior year.
• Other Non-Current Assets advanced to $32.4 million in Q1 2026, from $322000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $32.4 million in Q1 2022 to a low of $186000.0 in Q4 2023.
• A 5-year average of $15.4 million and a median of $369000.0 in 2023 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets slumped 99.43% — and 2025, when it surged 15321.9%.
• Tracing ELDN's Other Non-Current Assets over 5 years: stood at $32.4 million in 2022, then tumbled by 99.43% to $186000.0 in 2023, then jumped by 95.16% to $363000.0 in 2024, then slipped by 11.29% to $322000.0 in 2025, then surged by 9957.76% to $32.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $32.4 million (Q1 2026), $322000.0 (Q4 2025), and $32.4 million (Q3 2025), per Business Quant data.